2160. Emergence of INDEL Mutations in KPC-2: Insights into Ceftazidime-Avibactam and Imipenem-Relebactam Efficacy

BACKGROUND: Enterobacterales producing KPC-2 and KPC-3 β-lactamases (Bla) are a significant clinical threat. Ceftazidime/avibactam (CZA) and imipenem/relebactam (IMI/REL) are successful in the treatment for these infections. Unfortunately, CZA-resistant isolates are emerging as a result of amino aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Florencia, Bethel, Christopher R, Sanz, María Belén, Pasterán, Fernando, Gutkind, Gabriel, Gomez, Sonia, Bonomo, Robert A, Power, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677562/
http://dx.doi.org/10.1093/ofid/ofad500.1783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677562/
http://dx.doi.org/10.1093/ofid/ofad500.1783

Ejemplares similares